Quick Answer
Chemours Co reported Total Assets of $7.38 billion for the year ending 2025.
- Chemours Co showed a decrease of -2.2% in Total Assets from 2025 to 2025.
- This data is from Chemours Co's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2014 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: $6.69 billion | Q3 2015: $6.45 billion | Q1 2016: $6.38 billion | Q2 2016: $6.22 billion | Q3 2016: $6.29 billion | Q1 2017: $6.28 billion | Q2 2017: $7.05 billion | Q3 2017: $7.12 billion | Q1 2018: $7.48 billion | Q2 2018: $7.34 billion | Q3 2018: $7.51 billion | Q1 2019: $7.33 billion | Q2 2019: $7.43 billion | Q3 2019: $7.46 billion | Q1 2020: $6.95 billion | Q2 2020: $7.03 billion | Q3 2020: $6.95 billion | Q1 2021: $7.17 billion | Q2 2021: $7.48 billion | Q3 2021: $7.53 billion | Q1 2022: $7.52 billion | Q2 2022: $7.73 billion | Q3 2022: $7.75 billion | Q1 2023: $7.62 billion | Q2 2023: $7.66 billion | Q3 2023: $7.95 billion | Q1 2024: $7.98 billion | Q2 2024: $7.25 billion | Q3 2024: $7.46 billion.
- Over the full 15 years of available data (2014 to 2025), Chemours Co's Total Assets has grown by 23.9%.
- Historical annual values: Fiscal year 2025: $7.38 billion | Fiscal year 2025: $7.55 billion | Fiscal year 2025: $7.46 billion | Fiscal year 2025: $7.38 billion | Fiscal year 2024: $7.51 billion | Fiscal year 2023: $8.24 billion | Fiscal year 2022: $7.64 billion | Fiscal year 2021: $7.55 billion | Fiscal year 2020: $7.08 billion | Fiscal year 2019: $7.26 billion | Fiscal year 2018: $7.36 billion | Fiscal year 2017: $7.29 billion | Fiscal year 2016: $6.06 billion | Fiscal year 2015: $6.30 billion | Fiscal year 2014: $5.96 billion.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: